Clinical Trials Browser

Has results × Lapatinib × Tumor-Agnostic × Clear all

NCT00968968 2019-06-10

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Phase 3 Terminated

37 enrolled 11 charts

Carcinoma, Neoplasms

NCT01328054 2016-06-08

A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval

Phase 4 Completed

58 enrolled 17 charts

Neoplasms